BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 6995484)

  • 1. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
    Anderson CL; Stillman WS
    J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
    Starkebaum G; Arend WP
    J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Raji cell radioimmune assay for detecting immune complexes in human sera.
    Theofilopoulos AN; Wilson CB; Dixon FJ
    J Clin Invest; 1976 Jan; 57(1):169-82. PubMed ID: 128562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes.
    Horsfall AC; Venables PJ; Mumford PA; Maini RN
    Clin Exp Immunol; 1981 May; 44(2):405-15. PubMed ID: 6975676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
    Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
    J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody and immune complexes induce tissue factor production by human endothelial cells.
    Tannenbaum SH; Finko R; Cines DB
    J Immunol; 1986 Sep; 137(5):1532-7. PubMed ID: 3745915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding to histone of an anomalous IgG from patients with SLE and drug-induced lupus.
    Teodorescu M; Ustiyan V; Russo K; Rubin RL
    Clin Immunol; 2004 Feb; 110(2):145-53. PubMed ID: 15003811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.
    Medof ME; Scarborough D; Miller G
    Clin Exp Immunol; 1981 May; 44(2):416-25. PubMed ID: 7307341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
    Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
    J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.
    Glinski W; Gershwin ME; Steinberg AD
    J Clin Invest; 1976 Mar; 57(3):604-14. PubMed ID: 55418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auto-anti-anti-DNA antibodies from SLE patients and normals.
    Taniguchi O; Chia DS; Barnett EV
    J Rheumatol; 1984 Jun; 11(3):291-7. PubMed ID: 6610752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
    Medof ME; Oger JJ; Antel JP; Prince GM
    J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies to human fetal antigens in patients with systemic lupus erythematosus (SLE).
    Linker-Israeli M; Quismorio FP; Wong DK; Friou GJ
    J Immunol; 1980 Mar; 124(3):1154-9. PubMed ID: 6153671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
    Sagawa A; Abdou NI
    J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.
    Hall RP; Lawley TJ; Heck JA; Katz SI
    Clin Exp Immunol; 1980 Jun; 40(3):431-7. PubMed ID: 7418261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.